🧪 A new study led by Dr. Janani Durairaj and Prof. Torsten Schwede shows that current AI models in drug discovery still face limitations. Learn more👇 @ninjani.bsky.social @torstenschwede.bsky.social @unibas.ch @snsf.ch @natureportfolio.nature.com
www.biozentrum.unibas.ch/news/detail/...
Developing new medicines is a slow and costly process. For some years now, artificial intelligence (AI) has been considered a promising tool to accelerate drug discovery by identifying drug candidates...
